CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported profit of $7.7 million in its fourth quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had net income of 4 cents.
The regenerative medicine company posted revenue of $126.7 million in the period.
For the year, the company reported profit of $861,000, or 1 cent per share. Revenue was reported as $482 million.
Organogenesis expects full-year revenue in the range of $480 million to $535 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。